GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Lianhuan Pharmaceutical Co Ltd (SHSE:600513) » Definitions » Long-Term Debt

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Long-Term Debt : ¥79 Mil (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Jiangsu Lianhuan Pharmaceutical Co Long-Term Debt?

Jiangsu Lianhuan Pharmaceutical Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥79 Mil.

Jiangsu Lianhuan Pharmaceutical Co's quarterly Long-Term Debt increased from Sep. 2023 (¥70 Mil) to Dec. 2023 (¥79 Mil) but then stayed the same from Dec. 2023 (¥79 Mil) to Mar. 2024 (¥79 Mil).

Jiangsu Lianhuan Pharmaceutical Co's annual Long-Term Debt declined from Dec. 2021 (¥50 Mil) to Dec. 2022 (¥50 Mil) but then increased from Dec. 2022 (¥50 Mil) to Dec. 2023 (¥79 Mil).

Jiangsu Lianhuan Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Jiangsu Lianhuan Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Lianhuan Pharmaceutical Co Long-Term Debt Chart

Jiangsu Lianhuan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.00 44.00 49.90 49.65 79.00

Jiangsu Lianhuan Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.65 49.00 70.00 79.00 79.00

Jiangsu Lianhuan Pharmaceutical Co  (SHSE:600513) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Jiangsu Lianhuan Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Jiangsu Lianhuan Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Lianhuan Pharmaceutical Co Ltd (SHSE:600513) » Definitions » Long-Term Debt
Comparable Companies
SHSE:600080 SZSE:301111 SHSE:603811 SZSE:300534 SZSE:002107 SZSE:000153 SZSE:000790 SZSE:300436 SZSE:300016 SHSE:603538 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
N/A
Address
No. 21 Wenfeng Road, Jiangsu Province, Yangzhou, Jiangsu, CHN, 225009
Website
http://www.lhpharma.com
Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs.
Executives
Chu Qing Song senior management
Xia Chun Lai Director
Pan He Ping Directors, senior managers
Niu Ben senior management
Wu Wen Ge Director
Zhu Yong Jun senior management
Qian Zhen Hua Director
Shen Yi senior management
Huang Wen Tao senior management
Zhou Jun senior management
Tu Bin senior management
Qin Xiong Jian senior management

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Headlines

No Headlines